Digital Solutions for Medical Affairs Teams

Effectively reach patients, HCPs, sponsors, authorities, and more

Learn More
international marketing

Digital and technology-backed workflows to assist with content, localization, and management of medical affairs content

Historically, pharmaceutical companies have organized the medical affairs department regionally instead of globally by therapeutic area. While this structure may be closer to constituents, it can produce substantial regional differences in how organizations communicate medical information to patients and other stakeholders, potentially affecting the patient and stakeholder experience.

Evolve your medical affairs communications from a regional to global, integrated model with TransPerfect Life Sciences’ tptdigital solution for Med Affairs teams.

CONTACT US ›

360 Workflow Solutions To Meet Your Medical Affairs Initiatives

  • Content creation & adaption
  • SEO best practices
  • SEM global strategies
  • Social media management & strategy
  • Multilingual video creation
tpt dig

Enhancing Communications Globally for Key Stakeholders

Attract and keep your target audience’s attention with our specialized digital division’s support

Schedule a Free Consult ›

Improve customer engagement through innovative digital solutions and interactive content

Get in Touch ›

News and Press Releases

Our industry experts have in-depth understanding of the challenges, requirements, and goals for life sciences organizations.

Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them

Blog

In a recent "LifeSci Talks" episode, TransPerfect Global Practice Leader Mark Wade and Signant Health VP and eCOA Scientist Bill Byrom PhD discussed how new FDA guidance is reshaping how sponsors approach patient-reported outcomes (PROs) in cancer clinical trials. PROs are self-reported by patients and can be completed at the clinic or remotely (e.g., at home), often just before the patient begins a new treatment cycle. When assessments happen at this point, patients ...

Five Domains the FDA Wants You to Measure in PROs for Cancer—and Why Translation Affects All of Them
Webinar

Xtalks | Improve Recruitment Outcomes Through More Diverse Clinical Trials

Since the advent of artificial intelligence (AI), medical device manufacturers have been early adopters for product enhancements. Now, manufacturers are evaluating their regulated content and other production processes for suitable applications of AI and automation technology. ...
Blog

Potential Impact of the EU Biotech Act Proposal on Clinical Trial Activities

The European Commission’s proposed Biotech Act introduces changes that could reshape how clinical trials are approved and managed across the EU. While the broader package spans multiple areas of the health ecosystem, proposed updates to the EU Clinical Trial Regulation (EU...
Blog

5 Common eCOA Migration Issues

With so many clinical trials now using COAs on electronic platforms, the practice of “migration” (transferring and adapting COAs for electronic use) has become more common than ever. Without careful implementation, one minor deviation can compound across many languages,...
Checklist

A Checklist for eCOA Solution Deployment: Best Practices and Considerations

Selecting and deploying a new eCOA solution involves many important factors - from determining the capabilities of the Language Service Provider (LSP) to identifying the technology used for each COA migration - and it’s impossible not to worry about missing a key detail in the ...
Success Stories

Fortune 500 Pharma Company Meets Critical Deadlines with TransPerfect Life Sciences’ COA Solutions

This spotlight reviews the challenges faced by a Fortune 500 pharmaceutical company in implementing Clinical Outcome Assessments (COAs) to measure the impact of their products on patients. It discusses the need for accurate and culturally appropriate translations of COAs for ...
White Paper

Successful English Build & Language Migration

Over the past decade, the global clinical trial landscape has changed drastically. A surge in technological innovation, including wearable devices, patient portals, and apps, has modernized how clinical data is collected and managed. With pen and paper becoming obsolete in the ...

Ready to Enhance Your Relationship with Key Stakeholders?

How did you hear about us?
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.